Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T(reg) depletion

Despite the success of passive immunotherapy with monoclonal antibodies (mAbs), many lymphoma patients eventually relapse. Induction of an adaptive immune response may elicit active and long-lasting antitumor immunity, thereby preventing or delaying recurrence. Immunomodulating mAbs directed against...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Houot, Roch, Goldstein, Matthew J., Kohrt, Holbrook E., Myklebust, June H., Alizadeh, Ash A., Lin, Jack T., Irish, Jonathan M., Torchia, James A., Kolstad, Arne, Chen, Lieping, Levy, Ronald
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2009
Teme:
Lymphoid Neoplasia
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2765679/
https://ncbi.nlm.nih.gov/pubmed/19641184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-05-223958
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki